1. Home
  2. USCB vs LRMR Comparison

USCB vs LRMR Comparison

Compare USCB & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USCB Financial Holdings Inc.

USCB

USCB Financial Holdings Inc.

N/A

Current Price

$21.92

Market Cap

418.1M

Sector

Finance

ML Signal

N/A

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

N/A

Current Price

$3.06

Market Cap

455.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USCB
LRMR
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.1M
455.8M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
USCB
LRMR
Price
$21.92
$3.06
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $24.35
$14.40
AVG Volume (30 Days)
62.7K
★ 1.3M
Earning Date
10-22-2026
11-04-2026
Dividend Yield
★ 2.29%
N/A
EPS Growth
★ 7.26
N/A
EPS
★ 1.00
N/A
Revenue
N/A
N/A
Revenue This Year
$25.22
N/A
Revenue Next Year
$9.71
N/A
P/E Ratio
$22.51
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.36
$2.72
52 Week High
$23.89
$6.42

Technical Indicators

Market Signals
Indicator
USCB
LRMR
Relative Strength Index (RSI) 34.87 33.64
Support Level $17.83 $3.02
Resistance Level $23.66 $3.76
Average True Range (ATR) 0.45 0.20
MACD -0.18 -0.07
Stochastic Oscillator 9.43 15.36

Price Performance

Historical Comparison
USCB
LRMR

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: